Published in Chest on September 23, 2010
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ (2011) 6.19
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ (2012) 4.23
Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ (2012) 3.09
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation (2013) 2.73
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ (2015) 2.38
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis (2012) 1.45
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates. Nicotine Tob Res (2011) 1.10
Effective behaviour change techniques in smoking cessation interventions for people with chronic obstructive pulmonary disease: a meta-analysis. Br J Health Psychol (2013) 0.95
Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. Clin Pharmacol Ther (2014) 0.86
Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis. BMC Clin Pharmacol (2011) 0.85
Improved patient outcome with smoking cessation: when is it too late? Int J Chron Obstruct Pulmon Dis (2011) 0.84
Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis. BMC Fam Pract (2015) 0.81
Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother (2011) 0.81
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc (2016) 0.77
Smoking cessation interventions for adults aged 50 or older: A systematic review and meta-analysis. Drug Alcohol Depend (2015) 0.76
Impact of a countywide smoke-free workplace law on emergency department visits for respiratory diseases: a retrospective cohort study. BMC Pulm Med (2015) 0.76
Varenicline for smoking cessation intervention in chronic obstructive pulmonary disease. Expert Opin Pharmacother (2011) 0.75
Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression. Curr Med Res Opin (2016) 0.75
Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. BMC Med (2016) 0.75
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline. J Diabetes Investig (2016) 0.75
Exploring Issues of Comorbid Conditions in People Who Smoke. Nicotine Tob Res (2016) 0.75
What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD? Chest (2011) 0.75
Patient self-management in primary care patients with mild COPD - protocol of a randomised controlled trial of telephone health coaching. BMC Pulm Med (2015) 0.75
Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation. Appl Health Econ Health Policy (2016) 0.75